Skip to main content
Premium Trial:

Request an Annual Quote

Ingenuity Licenses Pathway-Analysis Software to Dutch Medical Center, Collaborates on New Applications

NEW YORK, March 23 (GenomeWeb News) - Ingenuity has licensed its Pathways Analysis software to Erasmus MC, a joint medical center of Erasmus University Rotterdam and the University Hospital Rotterdam in the Netherlands, the company said today.

 

Under the license, all researchers at Erasmus MC will have access to Ingenuity's software.

 

In addition, researchers at both institutions are collaborating to develop new algorithms, visualizations, and practical applications in molecular and clinical diagnostics. Moreover, Erasmus MC is involved in developing products in proteomics around applications from Ingenuity.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.